Phio Pharmaceuticals (PHIO) Presents at the American Association for Cancer Research Annual Meeting 2022 - Slideshow

3 12 5e05 5e05 anti-PD-1 mAb BP0146 clone RMP1-14 0.1 mg IP 1, 4, 7, 10, 13 4 12 5e05 5e05 PH-894 + anti-PD-1 mAb BP0146 clone RMP1-14 0.5 mg + 0.1 mg IT+ IP 1, 4, 7, 10, 13 Local administration of BRD4-targeting self-delivering RNAi (PH-894) provides abscopal efficacy toward untreated distal tumors and potentiates the efficacy of systemic anti-PD-1 antibody therapy #4237 Benjamin Cuiffo, Melissa Maxwell, Dingxue Yan, Shenghua Zhou, Brianna Rivest, Andrew Boone, James Cardia and Simon P. Fricker Abstract Im ...